Fined $3 Billion for Illegal Sales and Marketing of Drugs…but it’s just the cost of doing business / NY Times
From the NY Times: In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also…